OPKO Health是一家聚焦诊断与医药领域的医疗企业,核心业务涵盖医疗检测与药品研发生产,在纳斯达克和特拉维夫证券交易所挂牌上市,股票代码为OPK。
CSTL
CASTLE BIOSCIENCES INC
营收
$87.0M
净利润
N/A
FLGT
Fulgent Genetics, Inc.
$83.3M
$-23.4M
EBS
Emergent BioSolutions Inc.
$148.7M
$-54.6M
KRP
Kimbell Royalty Partners, LP
$82.5M
$24.8M
MIRM
Mirum Pharmaceuticals, Inc.
$148.9M
$-5.7M
BBIO
BridgeBio Pharma, Inc.
$154.2M
$-194.6M
XIFR
XPLR Infrastructure, LP
$249.0M
$28.0M
STOK
Stoke Therapeutics, Inc.
$158.6M
$112.9M